Clayton said the causes of HSDD in the study cohort were "biologically based" but that hypoactive sexual desire
disorder is a biopsychosocial condition.
Biopharmaceutical company Palatin Technologies Inc (NYSE MKT:PTN) reported on Monday the receipt of the US Patent and Trademark Office (USPTO) Notice of Allowance for use of Bremelanotide Methods for the treatment of hypoactive sexual desire
disorder in premenopausal women.
The prevalence of low sexual desire
with distress was higher in younger women and in surgically postmenopausal women (TABLE).
Flibanserin could help premenopausal women who have distressing low sexual desire
, which must be acquired and generalized:
This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire
Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Sprout has focused solely on the delivery of a treatment option for premenopausal women with acquired, generalized hypoactive sexual desire
disorder (HSDD) as characterized by low sexual desire
that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.
In a series of three phase III clinical trials in North America, premenopausal women who met the DSMTV diagnostic criteria for hypoactive sexual desire
disorder (HSDD) and who were in a stable monogamous relationship took flibanserin or placebo.
The movement to treat low desire using pharmaceutical interventions has led to potential concerns about pathologizing normal variation in female sexual desire
(Bancroft, Loffus, & Long, 2003; Tiefer, 2001).
At a joint meeting of two FDA advisory panels, members of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee voted 18 to 6 that the overall benefit-risk profile of flibanserin supported approval for treating hypoactive sexual desire
disorder (HSDD) in premenopausal women, provided that certain risk management options beyond labeling were implemented.
Most of the women had not discussed their low sexual desire
with their health care providers; they reported that they felt uncomfortable or embarrassed discussing the issue, and/or they were unaware that it is a medical condition that can be treated.
Washington, July 18 ( ANI ): A new study has revealed that eye movement of a person could tell the difference between their romantic love and sexual desire
Women usually face with sexual problems such as painful intercourse, lack of sexual desire
, vaginal dryness, and not reaching orgasm that lack of their knowledge could have serious damages to woman and with her husband.
Kak pointed to a long-held narrative that described female sexual desire
as passive, receptive, responsive and complex, while male desire is portrayed as spontaneous, driven, initiating and constant, an analysis that prompted a short outburst of laughter from the audience of mainly women.
This has had the impact of allowing people to argue that asexuality should be seen as nonpathological, by distinguishing it from the psychiatric diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM) of Hypoactive Sexual Desire
Disorder (HSDD)--defined as low sexual desire
accompanied by marked distress or interpersonal difficulties--without challenging either the diagnosis or the psychiatric institution governing it.
A/SEVERAL TREATMENTS produce modest, but statistically significant, clinical increases in sexual desire
and function in women.